Low level laser therapy for treating tuberculosis.

Author: MacLehoseH G, PechatnikovL M, VlassovV V

Paper Details 
Original Abstract of the Article :
BACKGROUND: The main treatment for tuberculosis is antituberculous drugs. Low energy laser therapy is used as an adjunct to antituberculous drugs, predominantly in the former Soviet Union and India. OBJECTIVES: To assess the benefits and harms of low level laser therapy for treating tuberculosis in...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/14651858.CD003490

データ提供:米国国立医学図書館(NLM)

Low Level Laser Therapy for Treating Tuberculosis: A Review

Tuberculosis (TB), a contagious bacterial infection, continues to be a major public health concern globally. This review examines the potential of low-level laser therapy (LLLT) as an adjunct treatment for TB. The researchers, like historians delving into ancient medical practices, sought to evaluate the evidence for this alternative approach to treating TB.

Evaluating the Evidence for Low Level Laser Therapy

The review systematically searched for relevant studies, but found no randomized or quasi-randomized controlled trials that met the inclusion criteria. This highlights the need for further rigorous research to determine the efficacy and safety of LLLT for treating TB. This review underscores the importance of evidence-based medicine in guiding medical practice.

The Need for Further Research

This review highlights the lack of strong scientific evidence to support the use of low-level laser therapy for treating tuberculosis. The findings emphasize the need for further research, particularly randomized controlled trials, to determine the effectiveness and safety of this approach.

Dr. Camel's Conclusion

This review reveals a lack of robust scientific evidence to support the use of low-level laser therapy for treating tuberculosis. The need for further research is evident, particularly well-designed clinical trials, to determine the efficacy and safety of this approach. It's crucial to rely on evidence-based medicine to guide medical practice and ensure the best possible outcomes for patients.

Date :
  1. Date Completed 2002-09-24
  2. Date Revised 2018-12-21
Further Info :

Pubmed ID

12137698

DOI: Digital Object Identifier

10.1002/14651858.CD003490

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.